October 14, 2015
Sanofi’s antiplatelet agent Plavix (clopidogrel) was the best-selling ethical drug in Japan in FY2014, topping the list for the second straight year, a Jiho tally showed. Plavix hauled in 124.8 billion yen, down 1.8% from the previous year, to retain...read more